Immune restoration in children after partial splenectomy

Area of Science:

• Pediatric Surgery
• Immunology
• Autoimmune Diseases

Background:

• Splenectomy (SE) treats severe autoimmune diseases and hypersplenism but increases infection risk due to immune organ removal.
• Partial splenectomy (PSE) aims to preserve spleen function while treating these conditions.
• Understanding long-term immune recovery after SE versus PSE is crucial for pediatric patients.

Purpose of the Study:

• To compare immune parameters in children following partial splenectomy (PSE) versus total splenectomy (SE).
• To assess the long-term immunological consequences of spleen preservation versus removal in pediatric patients.
• To evaluate the potential of PSE as a safer therapeutic alternative.

Main Methods:

• Longitudinal analysis of immune parameters in children post-PSE and post-SE for over 6 years.
• In vitro assessment of lymphocyte IgG production in response to pokeweed mitogen.
• Quantification of HLA-class II positive cells to evaluate immune regulation.

Main Results:

• Lymphocyte IgG production recovery was observed in PSE patients within 1-2 years, but not consistently in SE patients even after 10 years.
• Elevated HLA-class II positive cells were detected post-PSE, indicating altered immune regulation, which normalized alongside improved B cell activity.
• SE patients showed persistent deficits in IgG production, highlighting long-term immune compromise.

Conclusions:

• Partial splenectomy (PSE) demonstrates a superior immune recovery profile compared to total splenectomy (SE) in children.
• PSE may be a therapeutically advantageous alternative, preserving immune function while addressing specific pediatric conditions.
• Further research should explore the long-term benefits and indications for PSE in pediatric autoimmune diseases and hypersplenism.